Physician

Russell Lewis Gombosi, MD

According to 2025 Medicare claims, Russell Gombosi, MD (NPI: 1528078433) practices internal medicine in the Williamsport, PA market, with the plurality of this provider's patient population coming from Lycoming, PA. This provider's primary affiliated billing organization is OPEN ARMS INTERNAL MEDICINE & PEDIATRICS, PC (NPI: 1154834927; TIN: 823121291) and primary practice location at 17701-1032. Gombosi is affiliated with the Keystone ACO (ACO ID: A1552) and PA Clinical Network ACO Inc (ACO ID: A5030), participating under the MSSP model.

Gombosi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 447 traditional Medicare patients, billed 4,487 HCPCS/CPT codes, and received $191,000 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 10,164 prescription claims across 593 beneficiaries totaling $1,267,093 in drug costs, led by Eliquis (Apixaban). DME data shows 2,654 claims. Open Payments data shows 75 records totaling $1,516. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $111,479 to $191,000. Similarly, Part D prescription costs have risen steadily, from $529,746 to $1,267,093. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	473	1,775	$111,479
2016	423	1,185	$82,071
2017	141	290	$18,992
2018	351	1,738	$100,844
2019	475	3,655	$185,391
2020	471	4,718	$197,483
2021	484	5,555	$239,292
2022	503	7,304	$244,088
2023	485	4,459	$200,953
2024	447	4,487	$191,000

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	255	6,962	$529,746
2016	248	5,811	$452,883
2017	169	1,008	$83,331
2018	236	2,847	$214,426
2019	393	8,574	$722,395
2020	439	11,023	$947,367
2021	468	11,527	$1,097,197
2022	512	10,517	$1,172,205
2023	554	10,205	$1,211,866
2024	593	10,164	$1,267,093

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	954	2,458	$159,011
2016	1,061	2,754	$120,932
2017	1,044	2,359	$70,230
2018	1,127	2,422	$84,604
2019	1,288	2,915	$119,608
2020	1,357	2,885	$128,302
2021	1,224	2,589	$125,880
2022	1,074	2,242	$113,330
2023	1,171	2,778	$150,784
2024	1,087	2,654	$147,879

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	201	201	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	254	513	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	233	356	$59
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	89	120	$40
G0444	Annual depression screening, 5 to 15 minutes	204	204	$19

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	306	11,128	$211,942
Trulicity	Dulaglutide	70	2,864	$93,708
Ozempic	Semaglutide	61	2,534	$80,939
Jardiance	Empagliflozin	96	3,982	$74,010
Entresto	Sacubitril/Valsartan	62	2,804	$61,721

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7030	Full face mask used with positive airway pressure device, each	N	100	224	$24,518
A7031	Face mask interface, replacement for full face mask, each	N	75	181	$18,116
E0601	Continuous positive airway pressure (cpap) device	Y	62	358	$16,760
A4353	Intermittent urinary catheter, with insertion supplies	N	N/R	11	$14,716
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	85	183	$12,600

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	75	$1,516	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Russell Lewis Gombosi, MD?

Tedicare shows public-source Medicare data for Russell Lewis Gombosi, MD (NPI 1528078433), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Russell Lewis Gombosi, MD have ACO affiliation data?

Russell Lewis Gombosi, MD is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552) and PA Clinical Network ACO Inc (MSSP, ACO ID A5030).

What billing organization is linked to Russell Lewis Gombosi, MD?

Russell Lewis Gombosi, MD is linked to OPEN ARMS INTERNAL MEDICINE & PEDIATRICS, PC (billing NPI 1154834927) in the available physician profile data.

Does Russell Lewis Gombosi, MD have Open Payments data?

Russell Lewis Gombosi, MD has 75 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.